Skip to main content

Table 2 Cox regression analysis of factors potentially related to overall survival

From: Overall survival in response to sorafenib versus radiotherapy in unresectable hepatocellular carcinoma with major portal vein tumor thrombosis: propensity score analysis

  Log-rank test Cox
Covariates n Pvalue Pvalue HR 95% CI
Age (≥70/<70 y) 33/23 0.355    
Sex (male/female) 42/14 0.424    
HCV (present/absent) 34/22 0.58    
*Main trunk (present/absent) 16/40 0.612    
Extrahepatic spread (present/absent) 5/51 0.278    
Previous treatments (present/absent) 38/18 0.546    
AFP ≥ 100 (ng/dL) 28/28 0.073    
DCP ≥ 1000 (mAU/mL) 27 0.066 0.024 1  
<1000 29    0.508 0.282, 0.915
Sorafenib 28 0.002 0.007 1  
RT 28    0.434 0.235, 0.779
  1. Abbreviations: HCV hepatitis C virus, AFP α-fetoprotein, DCP des-γ-carboxy prothrombin, RT radiotherapy, HR hazard ratio, CI confidence interval.
  2. *Portal invasion to the main trunk.